Targacept Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Winston Salem NC United States (1997)
Status: Acquired by Catalyst Biosciences (2015)

Organization Overview

First Clinical Trial
2005
NCT00109564
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

TARGACEPT | Targacept Inc.